• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

朊病毒株现象:分子基础及前所未有的特征

The prion strain phenomenon: molecular basis and unprecedented features.

作者信息

Morales Rodrigo, Abid Karim, Soto Claudio

机构信息

Protein Misfolding Disorders Laboratory, George and Cynthia Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX 77555-0646, USA.

出版信息

Biochim Biophys Acta. 2007 Jun;1772(6):681-91. doi: 10.1016/j.bbadis.2006.12.006. Epub 2006 Dec 15.

DOI:10.1016/j.bbadis.2006.12.006
PMID:17254754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2597801/
Abstract

Prions are unconventional infectious agents responsible for transmissible spongiform encephalopathies. Compelling evidences indicate that prions are composed exclusively by a misfolded form of the prion protein (PrP(Sc)) that replicates in the absence of nucleic acids. One of the most challenging problems for the prion hypothesis is the existence of different strains of the infectious agent. Prion strains have been characterized in most of the species. Biochemical characteristics of PrP(Sc) used to identify each strain include glycosylation profile, electrophoretic mobility, protease resistance, and sedimentation. In vivo, prion strains can be differentiated by the clinical signs, incubation period after inoculation and the lesion profiles in the brain of affected animals. Sources of prion strain diversity are the inherent conformational flexibility of the prion protein, the presence of PrP polymorphisms and inter-species transmissibility. The existence of the strain phenomenon is not only a scientific challenge, but it also represents a serious risk for public health. The dynamic nature and inter-relations between strains and the potential for the generation of a large number of new prion strains is the perfect recipe for the emergence of extremely dangerous new infectious agents.

摘要

朊病毒是导致传染性海绵状脑病的非常规感染因子。有力证据表明,朊病毒仅由朊病毒蛋白的错误折叠形式(PrP(Sc))组成,其在没有核酸的情况下进行复制。朊病毒假说面临的最具挑战性的问题之一是感染因子存在不同毒株。在大多数物种中都已对朊病毒毒株进行了特征描述。用于鉴定每个毒株的PrP(Sc)的生化特性包括糖基化谱、电泳迁移率、蛋白酶抗性和沉降特性。在体内,朊病毒毒株可通过临床症状、接种后的潜伏期以及受感染动物大脑中的病变特征来区分。朊病毒毒株多样性的来源包括朊病毒蛋白固有的构象灵活性、PrP多态性的存在以及种间传播性。毒株现象的存在不仅是一项科学挑战,也对公共卫生构成严重风险。毒株之间的动态性质和相互关系以及产生大量新朊病毒毒株的可能性,是极其危险的新感染因子出现的完美条件。

相似文献

1
The prion strain phenomenon: molecular basis and unprecedented features.朊病毒株现象:分子基础及前所未有的特征
Biochim Biophys Acta. 2007 Jun;1772(6):681-91. doi: 10.1016/j.bbadis.2006.12.006. Epub 2006 Dec 15.
2
A closer look at prion strains: characterization and important implications.深入研究朊病毒株:特性与重要意义。
Prion. 2013 Mar-Apr;7(2):99-108. doi: 10.4161/pri.23490. Epub 2013 Jan 28.
3
The shifting biology of prions.朊病毒不断变化的生物学特性。
Brain Res Brain Res Rev. 2001 Oct;36(2-3):241-8. doi: 10.1016/s0165-0173(01)00100-x.
4
Insights into prion strains and neurotoxicity.对朊病毒株和神经毒性的见解。
Nat Rev Mol Cell Biol. 2007 Jul;8(7):552-61. doi: 10.1038/nrm2204.
5
Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.朊病毒疾病转基因小鼠模型对传播和发病机制的见解。
Methods Mol Biol. 2017;1658:219-252. doi: 10.1007/978-1-4939-7244-9_16.
6
Prion encephalopathies of animals and humans.动物和人类的朊病毒脑病
Dev Biol Stand. 1993;80:31-44.
7
Genetic and infectious prion diseases.遗传性和传染性朊病毒疾病。
Arch Neurol. 1993 Nov;50(11):1129-53. doi: 10.1001/archneur.1993.00540110011002.
8
The neuropathological phenotype in transgenic mice expressing different prion protein constructs.表达不同朊病毒蛋白构建体的转基因小鼠的神经病理表型。
Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):415-23. doi: 10.1098/rstb.1994.0038.
9
Recent advances in the histo-molecular pathology of human prion disease.人类朊病毒病的组织-分子病理学的最新进展。
Brain Pathol. 2019 Mar;29(2):278-300. doi: 10.1111/bpa.12695. Epub 2019 Jan 22.
10
Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).实验性瘙痒病啮齿动物和人类朊病毒病脑中蛋白激酶 MARK4 的减少与 PrP(Sc)的沉积相关。
Int J Mol Med. 2012 Sep;30(3):569-78. doi: 10.3892/ijmm.2012.1025. Epub 2012 Jun 12.

引用本文的文献

1
Distribution of chronic wasting disease (CWD) prions in tissues from experimentally exposed coyotes (Canis latrans).实验性暴露的郊狼(犬属)组织中慢性消耗病(CWD)朊病毒的分布
PLoS One. 2025 Jul 9;20(7):e0327485. doi: 10.1371/journal.pone.0327485. eCollection 2025.
2
Detection of prions in oocytes and ovaries of ewes naturally infected with classical scrapie.在自然感染经典羊瘙痒病的母羊的卵母细胞和卵巢中检测朊病毒。
Vet Res. 2025 Apr 10;56(1):79. doi: 10.1186/s13567-025-01512-0.
3
Detection of Prions in Wild Pigs (Sus scrofa) from Areas with Reported Chronic Wasting Disease Cases, United States.在美国有慢性消耗病病例报告地区的野猪(Sus scrofa)中朊病毒的检测
Emerg Infect Dis. 2025 Jan;31(1):168-173. doi: 10.3201/eid3101.240401.
4
Chaperone-mediated disaggregation of infectious prions releases particles that seed new prion formation in a strain-specific manner.伴侣蛋白介导的感染性朊病毒解聚释放出的颗粒,能以毒株特异性的方式引发新的朊病毒形成。
J Biol Chem. 2025 Jan;301(1):108062. doi: 10.1016/j.jbc.2024.108062. Epub 2024 Dec 9.
5
Adaptation of the protein misfolding cyclic amplification (PMCA) technique for the screening of anti-prion compounds.蛋白质错误折叠循环扩增(PMCA)技术的适应性改造及其在抗朊病毒化合物筛选中的应用。
FASEB J. 2024 Jul 31;38(14):e23843. doi: 10.1096/fj.202400614R.
6
Chronic Wasting Disease: State of the Science.慢性消耗病:科学现状
Pathogens. 2024 Feb 2;13(2):138. doi: 10.3390/pathogens13020138.
7
PMCA screening of retropharyngeal lymph nodes in white-tailed deer and comparisons with ELISA and IHC.检测白尾鹿咽后淋巴结中的 PMCA 并与 ELISA 和 IHC 进行比较。
Sci Rep. 2023 Nov 17;13(1):20171. doi: 10.1038/s41598-023-47105-9.
8
Development of a methodology for large-scale production of prions for biological and structural studies.开发用于生物和结构研究的朊病毒大规模生产方法。
Front Mol Biosci. 2023 Aug 10;10:1184029. doi: 10.3389/fmolb.2023.1184029. eCollection 2023.
9
Two structurally defined Aβ polymorphs promote different pathological changes in susceptible mice.两种结构定义明确的 Aβ 多形体在易感小鼠中促进不同的病理变化。
EMBO Rep. 2023 Aug 3;24(8):e57003. doi: 10.15252/embr.202357003. Epub 2023 Jul 10.
10
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.α-突触核蛋白构象揭示了与 α-突触核蛋白病临床异质性的联系。
Transl Neurodegener. 2023 Mar 14;12(1):12. doi: 10.1186/s40035-023-00342-4.

本文引用的文献

1
Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis.人类和家畜的朊病毒病:流行病学、遗传学及发病机制
J Neurochem. 2006 Jun;97(6):1726-39. doi: 10.1111/j.1471-4159.2006.03909.x.
2
Predicting susceptibility and incubation time of human-to-human transmission of vCJD.预测变异型克雅氏病的人际传播易感性和潜伏期。
Lancet Neurol. 2006 May;5(5):393-8. doi: 10.1016/S1474-4422(06)70413-6.
3
Species barriers in prion diseases--brief review.朊病毒疾病中的种属屏障——简要综述
Arch Virol Suppl. 2005(19):187-202. doi: 10.1007/3-211-29981-5_15.
4
Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.散发性克雅氏病中通过朊病毒蛋白(PrPSc)分析对朊病毒株的分析
PLoS Med. 2006 Feb;3(2):e14. doi: 10.1371/journal.pmed.0030014. Epub 2005 Dec 20.
5
Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiri sciureus).慢性消耗病朊病毒向松鼠猴(松鼠猴属)的种间传播。
J Virol. 2005 Nov;79(21):13794-6. doi: 10.1128/JVI.79.21.13794-13796.2005.
6
Chronic wasting disease.慢性消耗病
Vet Pathol. 2005 Sep;42(5):530-49. doi: 10.1354/vp.42-5-530.
7
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models.麋鹿慢性消耗病:通过转基因小鼠模型检测其对人类的传染性
J Neurosci. 2005 Aug 31;25(35):7944-9. doi: 10.1523/JNEUROSCI.2467-05.2005.
8
PrP glycoforms are associated in a strain-specific ratio in native PrPSc.在天然的朊病毒蛋白(PrPSc)中,朊病毒蛋白糖型以毒株特异性比例相关联。
J Gen Virol. 2005 Sep;86(Pt 9):2635-2644. doi: 10.1099/vir.0.80375-0.
9
Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral route.通过脑内途径将慢性消耗病病原体从骡鹿实验性传播给牛。
J Vet Diagn Invest. 2005 May;17(3):276-81. doi: 10.1177/104063870501700313.
10
Human prion diseases: molecular and clinical aspects.人类朊病毒病:分子与临床方面
Arch Neurol. 2005 Apr;62(4):545-52. doi: 10.1001/archneur.62.4.545.